Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Hlavní autoři: | , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Conference item |
Jazyk: | English |
Vydáno: |
American Society of Tropical Medicine and Hygiene
2019
|